Rigel Pharmaceuticals
RIGL
RIGL
162 hedge funds and large institutions have $365M invested in Rigel Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
22% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 55
27% less capital invested
Capital invested by funds: $500M → $365M (-$134M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
162
Holding in Top 10
1
Calls
$1.08M
Puts
$1.19M
Top Buyers
| 1 | +$8M | |
| 2 | +$4.93M | |
| 3 | +$3.38M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$3.15M |
| 5 |
Walleye Capital
New York
|
+$1.93M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$6.63M | |
| 3 | -$3.31M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.57M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$2.41M |